HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Olinger, G. N. Articles by Almassi, G. H. Search for Related Content PubMed PubMed Citation Articles by Olinger, G. N. Articles by Almassi, G. H.

The Journal of Thoracic and Cardiovascular Surgery, Vol 96, 141-149, Copyright © 1988 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Stratified application of the automatic implantable cardioverter defibrillator

GN Olinger, PD Chapman, PJ Troup and GH Almassi
Department of Cardiothoracic Surgery, Medical College of Wisconsin, Milwaukee 53226.

Since June 1983 we have developed a stratified regimen for staged implantation of the automatic implantable cardioverter defibrillator system. The protocol for management in patients who have fully recovered from sudden cardiac death is initiated with the use of standard electrophysiologic evaluation. Treatment in order of application has consisted of drugs followed by implantation of the device for patients with drug-refractory arrhythmias in whom direct cardiac surgical intervention for anatomic substrates for sudden death are absent. In surgical candidates, combinations of coronary revascularization and ablative therapy have been used to mitigrate the potential for lethal arrhythmia. Sensing and defibrillator lead systems have been placed at corrective operations to be followed later by implantation of the cardioverter defibrillator generator for either inducible or spontaneous tachyarrhythmia. This staged application has been effective in markedly reducing actual sudden cardiac death while at the same time saving on unnecessary device implantation. Morbidity of lead implantation alone remains a concern, particularly for infective complications. Additional follow-up is required to assess the validity of this approach.

This article has been cited by other articles:

				J. E. Molina Undertreatment and Overtreatment of Patients With Infected Antiarrhythmic Implantable Devices Ann. Thorac. Surg., February 1, 1997; 63(2): 504 - 509. [Abstract] [Full Text]

				D. M. Shahian, W. A. Williamson, F. J. Venditti Jr., D. T. Martin, and J. R. Ellis THE ROLE OF CORONARY REVASCULARIZATION IN RECIPIENTS OF AN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR J. Thorac. Cardiovasc. Surg., October 1, 1995; 110(4): 1013 - 1022. [Abstract] [Full Text]

				G. Hossein Almassi and G. N. Olinger Tunneling of defibrillator leads Ann. Thorac. Surg., March 1, 1989; 47(3): 486 - 486. [PDF]